2-178451030-T-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PVS1_ModerateBP6_Very_StrongBS2

The NM_003690.5(PRKRA):​c.1A>C​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,336,412 control chromosomes in the GnomAD database, including 6,399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 0 hom., cov: 34)
Exomes 𝑓: 0.13 ( 6399 hom. )

Consequence

PRKRA
NM_003690.5 initiator_codon

Scores

4
2
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.533

Publications

10 publications found
Variant links:
Genes affected
PRKRA (HGNC:9438): (protein activator of interferon induced protein kinase EIF2AK2) This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
PRKRA Gene-Disease associations (from GenCC):
  • dystonia 16
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 1 pathogenic variants. Next in-frame start position is after 26 codons. Genomic position: 178450401. Lost 0.081 part of the original CDS.
BP6
Variant 2-178451030-T-G is Benign according to our data. Variant chr2-178451030-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 332635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 6399 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKRANM_003690.5 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 8 ENST00000325748.9 NP_003681.1 O75569-1
PRKRANM_001316362.2 linkc.-449A>C 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 9 NP_001303291.1 B4DJC7
PRKRAXM_047446138.1 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 6 XP_047302094.1
PRKRANM_001316362.2 linkc.-449A>C 5_prime_UTR_variant Exon 1 of 9 NP_001303291.1 B4DJC7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKRAENST00000325748.9 linkc.1A>C p.Met1? initiator_codon_variant Exon 1 of 8 1 NM_003690.5 ENSP00000318176.4 O75569-1

Frequencies

GnomAD3 genomes
AF:
0.0474
AC:
5848
AN:
123394
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0245
Gnomad AMI
AF:
0.0745
Gnomad AMR
AF:
0.0503
Gnomad ASJ
AF:
0.0882
Gnomad EAS
AF:
0.0306
Gnomad SAS
AF:
0.0567
Gnomad FIN
AF:
0.0513
Gnomad MID
AF:
0.0992
Gnomad NFE
AF:
0.0601
Gnomad OTH
AF:
0.0452
GnomAD2 exomes
AF:
0.257
AC:
41222
AN:
160416
AF XY:
0.255
show subpopulations
Gnomad AFR exome
AF:
0.252
Gnomad AMR exome
AF:
0.262
Gnomad ASJ exome
AF:
0.255
Gnomad EAS exome
AF:
0.156
Gnomad FIN exome
AF:
0.256
Gnomad NFE exome
AF:
0.297
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.134
AC:
162052
AN:
1212914
Hom.:
6399
Cov.:
38
AF XY:
0.134
AC XY:
80350
AN XY:
601090
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0768
AC:
2136
AN:
27822
American (AMR)
AF:
0.237
AC:
8691
AN:
36652
Ashkenazi Jewish (ASJ)
AF:
0.183
AC:
4018
AN:
21974
East Asian (EAS)
AF:
0.0758
AC:
2528
AN:
33344
South Asian (SAS)
AF:
0.119
AC:
8488
AN:
71408
European-Finnish (FIN)
AF:
0.130
AC:
4545
AN:
35036
Middle Eastern (MID)
AF:
0.184
AC:
920
AN:
5000
European-Non Finnish (NFE)
AF:
0.133
AC:
124204
AN:
930764
Other (OTH)
AF:
0.128
AC:
6522
AN:
50914
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.305
Heterozygous variant carriers
0
12660
25320
37980
50640
63300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4796
9592
14388
19184
23980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0474
AC:
5851
AN:
123498
Hom.:
0
Cov.:
34
AF XY:
0.0461
AC XY:
2786
AN XY:
60438
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0245
AC:
894
AN:
36460
American (AMR)
AF:
0.0504
AC:
598
AN:
11858
Ashkenazi Jewish (ASJ)
AF:
0.0882
AC:
222
AN:
2516
East Asian (EAS)
AF:
0.0307
AC:
139
AN:
4530
South Asian (SAS)
AF:
0.0569
AC:
218
AN:
3830
European-Finnish (FIN)
AF:
0.0513
AC:
441
AN:
8590
Middle Eastern (MID)
AF:
0.0855
AC:
20
AN:
234
European-Non Finnish (NFE)
AF:
0.0601
AC:
3187
AN:
53016
Other (OTH)
AF:
0.0446
AC:
77
AN:
1726
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.258
Heterozygous variant carriers
0
735
1470
2205
2940
3675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
5
ExAC
AF:
0.383
AC:
31303

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dystonia 16 Benign:3
Jul 09, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 354/2178=16.25% -

Hearing loss, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dystonic disorder Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
21
DANN
Benign
0.92
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.36
N
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.98
D
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.53
PROVEAN
Benign
-0.77
N
REVEL
Uncertain
0.37
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.21
T
Polyphen
0.0
B
Vest4
0.29
MutPred
0.92
Loss of catalytic residue at M1 (P = 0.0205);
ClinPred
0.14
T
GERP RS
3.3
PromoterAI
-0.33
Neutral
Varity_R
0.94
gMVP
0.44
Mutation Taster
=124/76
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9406386; hg19: chr2-179315757; COSMIC: COSV57867895; COSMIC: COSV57867895; API